Skip to content

Evaluation of Human Efficacy of SOD Like Super Drink

Evaluation of Human Efficacy of SOD Like Super Drink

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06322589
Enrollment
50
Registered
2024-03-21
Start date
2024-03-01
Completion date
2024-06-30
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatology

Keywords

Skin analysis, Skin care products

Brief summary

To assess the efficacy of SOD like Super Drink on anti-oxidant capacity, immuno regulation and skin for human

Interventions

DIETARY_SUPPLEMENTSOD like Super Drink

consume 1 bottle per day

DIETARY_SUPPLEMENTplacebo drink

consume 1 bottle per day

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy adults aged between 30-65 years old

Exclusion criteria

* Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder * Patients with diseases of the skin, liver, kidney. * Female who is pregnant or nursing or planning to become pregnant during the course of the study. * Received facial laser therapy, chemical peeling or UV overexposure (\> 3 hr/week) in the past 4 weeks. * Students who are currently taking courses taught by the principal investigator of this trial.

Design outcomes

Primary

MeasureTime frameDescription
the change of immune-related cytokines of bloodChange from Baseline immune-related cytokines at 8 weeksvenous blood was sampled to measure immune-related cytokines
the roughness of skin textureRating skin roughness from Baseline skin texture at 8 weeksIRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units
the change of skin elasticityChange from Baseline skin elasticity at 8 weeksCutometer® was utilized to measure skin elasticity. Units: arbitrary units
the change of Total Anti-oxidative Capacity (TAC) of bloodChange from Baseline TAC at 8 weeksvenous blood was sampled to measure TAC
the change of Superoxide Dismutase (SOD) of bloodChange from Baseline SOD at 8 weeksvenous blood was sampled to measure SOD
the change of Glutathione S-transferase (GST) of bloodChange from Baseline GST at 8 weeksvenous blood was sampled to measure GST
the change of Glutathione (GSH) of bloodChange from Baseline GSH at 8 weeksvenous blood was sampled to measure GSH
the change of Malondialdehyde (MDA) of bloodChange from Baseline MDA at 8 weeksvenous blood was sampled to measure MDA
the volume of skin wrinklesVolume change from Baseline skin wrinkles at 8 weeksIRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units

Secondary

MeasureTime frameDescription
the change of Skin Melanin IndexChange from Baseline skin Melanin Index at 8 weekMexameter® MX 18was utilized to measure Melanin Index. Units: arbitrary units
the change of skin Transepidermal Water Loss (TEWL)Change from Baseline TEWL at 8 weekTewameter® TM 300 was utilized to measure TEWL. Units: arbitrary units
the change of skin surface hydrationChange from Baseline skin surface hydration at 8 weekCorneometer® CM 825 was utilized to measure skin surface hydration. Units: arbitrary units
the change of Skin Erythema IndexChange from Baseline skin Erythema Index at 8 weekMexameter® MX 18was utilized to measure skin Erythema Index. Units: arbitrary units

Other

MeasureTime frameDescription
The change of self-assessment skin condition and immuno conditionChange from Baseline skin condition and immunol condition at 8 weeksA self-assessment questionnaire was collected to evaluate skin condition and immunol condition,As for the evalutation of skin condition ,the higher score the better;As for evaluation of immunol condition , the higher score the worse
The change of liver function biomarkers (AST, ALT) of bloodChange from Baseline liver function biomarkers at 8 weeksVenous blood was sampled to measure liver function biomarkers
The change of renal function biomarkers (creatinine, BUN) of bloodChange from Baseline renal function biomarkers at 8 weeksVenous blood was sampled to measure renal function biomarkers

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026